SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-127596
Filing Date
2022-04-28
Accepted
2022-04-28 16:16:54
Documents
5
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d356025ddef14a.htm DEF 14A 291473
2 GRAPHIC g356025dsp035.jpg GRAPHIC 107920
3 GRAPHIC g356025dsp036.jpg GRAPHIC 90195
4 GRAPHIC g356025g02r02.jpg GRAPHIC 37873
5 GRAPHIC g356025g65k21.jpg GRAPHIC 15905
  Complete submission text file 0001193125-22-127596.txt   628417
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39971 | Film No.: 22866778
SIC: 2834 Pharmaceutical Preparations